A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lori J Goldstein, MD
FASCOFox Chase Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
77 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Algemeen Ziekenhuis Klina
Brasschaat, Belgium
- Cliniques Universitaires Saint- Luc Ucl
Brussels, Belgium
- Universitair Ziekenhuis Antwerpen
Edegem, Belgium
- Chu Ambroise Paré
Mons, Belgium
- Az St Elisabeth
Namur, Belgium
- Masaryk Memorial Cancer Institute
Brno, Czechia
- Nemocnice Horovice A.S.
Hořovice, Czechia
- Fakultni Nemocnice Hradec Králové
Hradec Králové, Czechia
- Fakultní Nemocnice Královské Vinohrady
Prague, Czechia
- Fakultní Nemocnice V Motole, Onkologická Klinika 2. Lf Uk A Fn Motol
Prague, Czechia
- Onkologická Klinika Vfn A 1.Lf Uk
Prague, Czechia
- Krajská Nemocnice T.Bati, A. S.
Zlín, Czechia
- Centre Paul Papin
Angers, France
- Centre François Baclesse
Caen, France
- Centre Hospitalier de Saint-Brieuc, Yves Le Foll
La Roche-sur-Yon, France
- Centre Hospitalier Universitaire (chu) de Limoges - Hopital Dupuytren
Limoges, France
- Institut Paoli Calmettes
Marseille, France
- Centre Antoine Lacassagne
Nice, France
- Hôpital Européen Georges Pompidou
Paris, France
- Medicale Centre René Gauducheau
Saint-Herblain, France
- Ospedale "di Summa-Perrino"
Brindisi, Italy
- Azienda Ospedaliero-Universitaria
Cagliari, Italy
- Azienda Ospedaliero - Universitaria, Policlinico Vittorio Emanuele
Catania, Italy
- Istituto Scientifico Romagnolo Per Lo Studio E la Cura Dei Tumori
Meldola, Italy
- Ospedale Dell'Angelo
Mestre, Italy
- Azienda Ospedaliera, Ospedale San Carlo Borromeo
Milan, Italy
- Istituto Europeo Di Oncologia
Milan, Italy
- Fondazione Irccs Policlinico S. Matteo
Pavia, Italy
- Azienda Ospedaliera Ospedali Riuniti Marche Nord
Pesaro, Italy
- Nuovo Ospedale
Prato, Italy
- Azienda Opspedaliero Universitaria Santa Maria Della Misericordia
Udine, Italy
- Ospedale Ss Giovanni E Paolo
Venezia, Italy
- Bialostockie Centrum Onkologii Im. Marii Sklodowskiej - Curie
Bialystok, Poland
- Wojewódzkie Centrum Onkologii
Gdansk, Poland
- Centrum Onkologii Ziemi Lubelskiej Im. Sw. Jana Z Dukli
Lublin, Poland
- Uniwersytet Medyczny Im. Karola Marcinkowskiego W Poznaniu
Poznan, Poland
- Mrukmed. Lekarz Beata Madej Mruk I Partner. Spólka Partnerska Oddzial Nr 1 W Rzeszowie
Rzeszów, Poland
- Magodent Sp. Z O. O.
Warsaw, Poland
- Centro Oncológico Regional de Galicia, Servicio de Oncologia Medica
A Coruña, Galicia, Spain
- Complejo Hospitalario Universitario la Coruña
A Coruña, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jul 2015
- Primary completion
- 20 Feb 2019
- Completion
- 23 Mar 2020
- Last update posted
- 16 Sept 2022
- Registered enrollment
- 194
- Registry id
- NCT02370238
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.